PillErythromycin
Erythromycin
13 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 15 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it13 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | unknown | 12 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 8 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 6 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 6 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 6 | SUPPLYING |
| Modavar Pharmaceuticals LLC | unknown | 4 | SUPPLYING |
| Arbor Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| Nivagen Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| Cadila Pharmaceuticals Limited | unknown | 4 | SUPPLYING |
| Orange Pharmaceuticals USA LLC | unknown | 4 | SUPPLYING |
| Wilshire Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 29, 2026RECALLRecall (Class II): Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,…
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide within the U.S
- Apr 29, 2026RECALLRecall (Class II): Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,…
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide within the U.S